Author: StarkAge Therapeutics

Posted Date:

May 2, 2026

New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026

StarkAge Therapeutics

May 2, 2026
StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers

StarkAge Therapeutics

February 2, 2026